These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38958473)

  • 21. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic biology for pharmaceutical drug discovery.
    Trosset JY; Carbonell P
    Drug Des Devel Ther; 2015; 9():6285-302. PubMed ID: 26673570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between target-class and the physicochemical properties of antibacterial drugs.
    Mugumbate G; Overington JP
    Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
    Matzner D; Mayer G
    J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
    Abouelhassan Y; Garrison AT; Yang H; Chávez-Riveros A; Burch GM; Huigens RW
    J Med Chem; 2019 Sep; 62(17):7618-7642. PubMed ID: 30951303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current landscape in the discovery of novel antibacterial agents.
    Vila J; Moreno-Morales J; Ballesté-Delpierre C
    Clin Microbiol Infect; 2020 May; 26(5):596-603. PubMed ID: 31574341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation.
    Qiu Z; Huang R; Wu Y; Li X; Sun C; Ma Y
    Microb Drug Resist; 2024 Jun; 30(6):254-272. PubMed ID: 38648550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A metabolic network approach for the identification and prioritization of antimicrobial drug targets.
    Chavali AK; D'Auria KM; Hewlett EL; Pearson RD; Papin JA
    Trends Microbiol; 2012 Mar; 20(3):113-23. PubMed ID: 22300758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial natural products in medicinal chemistry--exodus or revival?
    von Nussbaum F; Brands M; Hinzen B; Weigand S; Häbich D
    Angew Chem Int Ed Engl; 2006 Aug; 45(31):5072-129. PubMed ID: 16881035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens.
    Fallarero A; Hanski L; Vuorela P
    Planta Med; 2014 Sep; 80(14):1182-99. PubMed ID: 25221978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of marine natural products against drug-resistant bacterial infections.
    Liu M; El-Hossary EM; Oelschlaeger TA; Donia MS; Quinn RJ; Abdelmohsen UR
    Lancet Infect Dis; 2019 Jul; 19(7):e237-e245. PubMed ID: 31031171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.
    Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R
    Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotics: past, present and future.
    Hutchings MI; Truman AW; Wilkinson B
    Curr Opin Microbiol; 2019 Oct; 51():72-80. PubMed ID: 31733401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial drug discovery in the resistance era.
    Brown ED; Wright GD
    Nature; 2016 Jan; 529(7586):336-43. PubMed ID: 26791724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-Generation Drug Discovery to Combat Antimicrobial Resistance.
    Niu G; Li W
    Trends Biochem Sci; 2019 Nov; 44(11):961-972. PubMed ID: 31256981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natural products in clinical trials: antibacterial and antifungal agents].
    Han L; Zheng D; Huang XS; Yu SS; Liang XT
    Yao Xue Xue Bao; 2007 Mar; 42(3):236-44. PubMed ID: 17520820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural product derived promising anti-MRSA drug leads: A review.
    Gatadi S; Gour J; Nanduri S
    Bioorg Med Chem; 2019 Sep; 27(17):3760-3774. PubMed ID: 31324564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials.
    Walesch S; Birkelbach J; Jézéquel G; Haeckl FPJ; Hegemann JD; Hesterkamp T; Hirsch AKH; Hammann P; Müller R
    EMBO Rep; 2023 Jan; 24(1):e56033. PubMed ID: 36533629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.